In vitro competitive binding studies comparing the parent drug with labeled gemcitabine showed a decreasing trend in fluorescence intensity with increased unlabeled gemcitabine concentration co-incubation in the gemcitabine sensitive PANC-1 cell lines, although variability was high ( S3 Fig ).
← all excerpts
Quantification of fluorophore distribution and therapeutic response in matched in vivo and ex vivo pancreatic cancer model systems.
1
—
—